Celyad (CYAD) Priced

Belgian biotech developing gene therapies for cardiovascular diseases and cancer.

Health Care - Biotechnology

IPO Performance
Latest Trade $21.60 0.00 (0.0%)
First Day Return -20.4%
Return from IPO -68.5%
 
Celyad IPO News more
  • .
IPO Data
IPO File Date 05/18/2015
Offer Price $68.56
Price Range $68.56 - $68.56
Offer Shares (mm) 1.5
Deal Size ($mm) 100
 
IPO Data
IPO Date 06/18/2015
Offer Price $68.56
Price Range $68.56 - $68.56
Offer Shares (mm) 1.5
Deal Size ($mm) $100
 
Underwriters
more
Business Overview
Belgian biotech developing gene therapies for cardiovascular diseases and cancer.
Belgian biotech developing gene therapies for cardiovascular diseases and cancer.
more
Company Data
Headquarters Mont-Saint-Guibert, , Belgium
Founded 2007
Employees 82
Website www.celyad.com
 

Performance vs. IPO Index (IPOUSA)